| 0 (0%) | 02-21 15:55 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.22  |
1-year : | 1.36 |
| Resists | First : | 1.05 |
Second : | 1.16 |
| Pivot price | 0.95 |
|||
| Supports | First : | 0.85 | Second : | 0.71 |
| MAs | MA(5) : | 0.97 |
MA(20) : | 0.97 |
| MA(100) : | 1.04 |
MA(250) : | 1.34 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 64.9 |
D(3) : | 55.4 |
| RSI | RSI(14): 52.7 |
|||
| 52-week | High : | 2.67 | Low : | 0.85 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ COCP ] has closed below upper band by 11.2%. Bollinger Bands are 39.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.01 - 1.02 | 1.02 - 1.02 |
| Low: | 0.95 - 0.95 | 0.95 - 0.96 |
| Close: | 1 - 1.01 | 1.01 - 1.02 |
Thu, 19 Feb 2026
Cocrystal Highlights CDI-988 Norovirus Data at ICAR 2026 - TipRanks
Thu, 19 Feb 2026
First oral norovirus drug candidate at major antiviral meeting - Stock Titan
Tue, 17 Feb 2026
Will COCP benefit from green energy policies - 2025 Retail Activity & Stock Portfolio Risk Management - mfd.ru
Sun, 15 Feb 2026
How COCP stock trades before earnings - 2025 AllTime Highs & Daily Stock Trend Reports - mfd.ru
Mon, 29 Dec 2025
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $63k - Investing.com
Thu, 18 Dec 2025
Human trial of first oral drug to fight norovirus cleared at Emory - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 14 (M) |
| Shares Float | 9 (M) |
| Held by Insiders | 32.4 (%) |
| Held by Institutions | 4.8 (%) |
| Shares Short | 160 (K) |
| Shares Short P.Month | 127 (K) |
| EPS | -0.94 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.58 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -45.8 % |
| Return on Equity (ttm) | -95 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | -0.4 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.71 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -10 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | -1.09 |
| PEG Ratio | 0 |
| Price to Book value | 1.7 |
| Price to Sales | 0 |
| Price to Cash Flow | -1.45 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|